This study investigated the impact of human immunodeficiency virus (HIV) infection on genital human papillomavirus (HPV) in heterosexual couples. More HIV-positive men and women had genital HPV compared with HIV-negative men (77 vs 49 %; P,0.001) and women (74 vs 36 %; P,0.001). More men and women with partners who were HPV positive had HPV genital infection compared with those with HPV-negative partners (for men, 72 % compared with 40 %; P,0.001). Men with HIV-positive female partners were at greater risk of high-risk HPV and lowrisk HPV (LR HPV) infection compared with men with HIV-negative female partners. This risk increased with decreasing CD4 count {¢350 ml of any type was not found to differ between women with an HIV-positive or HIV-negative male partner. In men, HIV infection and female partner HIV-positive status were both associated with a higher risk of type-specific HPV concordance with their sexual partner, though the associations were not significant for LR HPV. In women, HIV infection and low CD4 count were significantly associated with increased risk of type-specific HPV concordance, but male partner HIV-positive status was not significantly associated with this concordance. In conclusion, male genital HPV prevalence and type-specific sharing were influenced by their own HIV-positive status and that of their female partner. In contrast, female genital HPV prevalence and HPV type-specific sharing were determined by their own HIV-positive status and not by that of their male partner.
INTRODUCTION
More than 200 different human papillomavirus (HPV) types have been identified (Jung et al., 2004) . HPV types are divided into two groups, cutaneous and mucosal. Mucosal HPVs infect the mucous membranes of the genital tract, oral cavities, conjunctiva and respiratory tract (Gross & Pfister, 2004) . Mucosal HPV types are described as either high-risk (HR) or low-risk (LR) HPV types, according to their association with cervical cancer. HR HPV types are associated with the development of low-grade cervical neoplasia, high-grade cervical neoplasia and cervical cancer, while LR HPV types are associated with the development of genital warts and/or low-grade cervical neoplasia (Munoz et al., 2003) .
HPV is the most common sexually transmitted virus and 75 % of sexually active women and men will acquire a genital HPV infection at some time. The highest prevalence of HPV infection is observed in young women and men, soon after sexual debut (Kjaer et al., 2001; Palefsky, 2007; Schiffman & Castle, 2005) . Winer et al. (2008) reported a 28.5 % incidence of HPV infection in women within 1 year after first intercourse with their only male partner. Cumulative HPV incidence was increased to 39.2 % at 2 years and to 49.1 % at 3 years after sexual debut. It was noted that in women with male partners who had 2 or more female partners the risk of HPV incidence was increased compared with those women with male partners who had only one female partner (Winer et al., 2008) . HPV infection decreases with increasing age, and young women have a higher prevalence of multiple infections than older women (Cuschieri et al., 2004; Kjaer et al., 2000) . Mbulawa et al., 2009) . HIV-positive women progress to cervical cancer about 10 years earlier than HIV-negative women (Lomalisa et al., 2000) . We previously showed that HIV infection in one or both partners has a significant impact on the prevalence of HPV genital infection in the other partner (Mbulawa et al., 2009) .
Women with male sexual partners with HPV infection and/ or flat penile lesions are more likely to acquire HPV infection and to develop cervical disease later (Heard et al., 2000) . Men with female sexual partners with cervical or vulval HPV-associated cancer are at an increased risk of becoming infected by HPV and developing penile lesions (Bleeker et al., 2002 (Bleeker et al., , 2005 . According to Bleeker et al. (2002) , the rate of flat penile lesion regression is low in males with female sexual partners who are HPV-positive with the same HPV type compared with those men with sexual partners who are HPV negative, suggesting that HPV reinfection between partners may play an important role in this scenario.
We previously reported on data from 254 heterosexually active couples (Mbulawa et al., 2009 ) documenting HPV prevalence, HPV total isolates and the specific genotypes prevalent in HIV-positive and HIV-negative women and men. We also reported on the number of HPV types shared, expected and observed between HIV-negative, HIV-positive and HIV-discordant couples. Finally, we demonstrated the effect of female HPV viral load and CD4 count on HPV sharing between couples. In the present report we present data from an expanded sample of 486 heterosexually active couples. We examined the role of factors influencing HPV prevalence in men and women such as CD4 count, number of lifetime sexual partners, age at first intercourse and the number of sexual acts with the study partner in the last month. The influence of a partner's HPV positivity on the HPV prevalence in women and men, and the impact of the HIV configuration of the partnership were also investigated. We demonstrate the effect of the partner's HIV status and CD4 count on the prevalence of any HPV, HR HPV and LR HPV, in men and women, as well as the factors associated with type-specific HPV sharing in men and women.
RESULTS
HPV prevalence in women and men, and the impact of HIV and other variables
In an unadjusted analysis (Table 1) HIV-positive men had a significantly higher HPV prevalence compared with HIVnegative men (77 % compared with 49 %; P,0.001). HIVpositive women were also found to have a higher HPV prevalence compared with HIV-negative women (74 % compared with 36 %; P,0.001). Among HIV-positive men the most frequently detected types were HPV-62 (20.8 %), , , HPV-53 (16.1 %), HPV-89 and -45 (14.8 %) and HPV-55, -81, -83 and -16 (13.4 %). Among HIV-negative men HPV-62 (8.1 %), HPV-61 (6.8 %), HPV-66 (6.5 %), HPV-53 (6.2 %), HPV-83 (5.9 %), HPV-81 (5.3 %) and HPV-89, -16 and -51 (5.0 %) were most frequently detected. Among HIV-positive women the most frequently detected HPV types were HPV-62 (12.6 %), HPV-52 (11.2 %), HPV-58 (10.1 %), HPV-53 (9.7 %), HPV-61 and -16 (9 %), and . Among HIV-negative women HPV-11 (5.3 %), HPV-6 (4.3 %) and were frequently detected (Fig. 1 . HPV prevalence was found to decrease significantly with increasing age in both men (P50.007) and women (P,0.001). In the unadjusted analysis, for both women and men HPV prevalence was not influenced by whether they lived with their sexual partners, by the duration of the relationship, or by their number of lifetime sexual partners (Table 1) . Similarly, in men and women, young age at first sexual intercourse did not significantly influence HPV prevalence, nor did the number of sexual acts with the study partner in the last month (Table 1) .
Influence of a sexual partner's HPV-positive status on genital HPV prevalence and the impact of HIV configuration of the partnership HPV infection was significantly higher in men with female partners who were HPV positive compared with men with female partners who were HPV negative (72 % compared with 40 %; P,0.001, Table 2 ). Similarly, more women had genital HPV if their male partners were HPV positive compared with women with male partners who were HPV negative (72 % compared with 40 %; P,0.001). However, this increased HPV prevalence was influenced by HIV coinfection, the risk being higher in women and men from a partnership where both partners were HIV positive or where only the female partner was HIV positive, and lower in partnerships where both partners were HIV negative. In HIV-discordant couples where the male partner was HIV positive, genital HPV prevalence was also higher in women and men with HPV-positive partners compared with those whose partners were HPV negative, although the difference was not statistically significant ( Table 2) .
Influence of HIV infection and other factors on HPV prevalence in men
In the adjusted assessment, for men the risk of having any HPV type and any HR HPV was found to significantly decrease with increasing age [adjusted odds ratio (AOR), 0.77 (95 % CI, 0.63-0.93) and AOR, 0.70 (95 % CI, 0.57-0.86), respectively, per 10 year increase in age] (Table 3 ). In contrast, the risk of having LR HPV did not significantly decrease with increasing age in men (Table 3) . HIVpositive men were found to be at higher risk of infection by any HPV type compared with HIV-negative men, and the risk was found to increase with decreasing CD4 count levels [CD4 counts of ¢350 ml
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: AOR, 2.54 (95 % CI, Table 3) . None of the sexual behaviour characteristics were included in the multivariate analysis as they did not significantly affect male HPV risk.
Men with HIV-positive female partners were found to be at higher risk of infection by any HPV, HR HPV and LR HPV compared with men with HIV-negative female partners. Table 3) .
Influence of HIV infection and other factors on HPV prevalence in women
In the adjusted assessment for women, the risk of having any HPV type was found to significantly decrease with increasing age and the same relationship was observed for HR HPV and LR HPV types (Table 4) . HIV-positive women were found to be at a higher risk of infection by any HPV type compared with HIV-negative women, and the risk was found to increase with decreasing CD4 count levels [CD4 counts of ¢350 ml Table 4 ). The risk of HPV infection was not found to differ between women with an HIV-positive male partner and women with an HIV-negative male partner, either for HR or LR types. Neither the HIV-positive status nor the CD4 count of the male partner influenced HPV prevalence in women (Table 4) .
Effect of the partner's HIV status on type-specific HPV concordance among couples Type-specific HPV concordance among couples was defined as the presence of the same HPV genotypes in the cervical and penile cells of a couple. In HIV-negative couples, 10 % (16/155) showed type-specific HPV concordance; among these couples 15 shared one HPV type while one couple shared two HPV types. In HIV-positive couples, 48 % (54/ 112) showed type-specific HPV concordance; 28 couples shared one HPV type and 26 shared -two to ten HPV types. In HIV-discordant couples where the female partner was HIV positive, 30 % (47/158) showed HPV type-specific concordance; 22 couples shared one HPV type and 25 couples shared two to eleven HPV types. In HIV-discordant Effect of HIV on HPV in sexually active partners couples where the male partner was HIV positive, 11 % (5/44) showed type-specific HPV concordance; three couples shared one HPV type and two couples shared two HPV types (Table 5 ).
Finally, in the adjusted assessment, for men, HIV infection and female partner HIV-positive status were both associated with a higher risk of sharing the same HPV type as their sexual partner, though the associations were not significant for LR HPV types. For women, HIV infection and low CD4 count were significantly associated with an increased risk of type-specific HPV sharing, but their male partner's HIV-positive status was not significantly associated with this type-specific HPV sharing (Table 6 ). The risk of type-specific HPV sharing was not significantly associated with demographic characteristics or reported sexual behaviour, in either men or women.
DISCUSSION
This study examined in detail the relationship between HIV and HPV prevalence. It is, to our knowledge, the first study to simultaneously assess the associations between HPV and the HIV status of both an individual and that of their partner. It is also the first report to demonstrate the influence of the partner's HIV-positive status on HPV prevalence in women and men from HIV-concordant and HIV-discordant relationships. An individual's HIV infection was associated with increased genital HPV in both men and women, with a stronger association with decreasing CD4 count in women than in men. The association with a partner's HIV status only held for HIV-infected female partners of men, and was not CD4 count dependent here. These findings were consistent for both LR and HR HPV. Among those with HPV infection, sharing of types followed similar patterns to HIV association.
The distribution of different HPV genotypes in HIVpositive and HIV-negative women and men was found to be similar to that in our previous report (Mbulawa et al., 2009) . HIV-positive women and men had more genital HPV compared to HIV-negative women and men, respectively, and low CD4 count influenced HPV prevalence, as has been reported earlier by our laboratory and others (Riva et al., 2007; Mbulawa et al., 2009) . HPV incidence is reported to be high in HIV-positive individuals due to a suppressed immune system (Strickler et al., 2005) . Generally, LR HPV types were more prevalent among HIV-negative men compared with HIV-negative women. In this study, samples from women were only collected at the cervix while a single swab from men sampled penile shaft, glans and foreskin (in uncircumcised men). Therefore the higher LR HPV prevalence in men compared with women could be due to the fact that women were only sampled at the cervix and not the vagina. It has been reported that more LR types are likely to be detected in specimens from the vagina than in samples from the cervix (Jones et al., 2007) . The risk of HPV infection was found to decrease with increasing age in women and men. This has been reported previously (Kjaer et al., 2000; Cuschieri et al., 2004) , although in this study the risk of having LR HPV types did not significantly decrease with age in men. It has been reported that women with multiple lifetime sexual partners have a higher HPV prevalence compared with women with fewer lifetime sexual partners (Svare et al., 2002; Burchell et al., 2010) . In our study multiple sexual partners, duration of relationship and the age at first sex did not have a significant impact on HPV prevalence in women or men.
Men with HIV-positive female partners were also found to have a higher risk of infection by any HPV, HR HPV and LR HPV compared with men with HIV-negative female partners. However, women with HIV-positive male partners were not found to have a higher risk of infection by any HR, HR HPV or LR HPV compared with women with HIVnegative male partners. These findings suggest that women's HPV risk is influenced only by their own HIV status, while HPV prevalence in men is determined by their own HIVpositive status and by that of their female partner.
We demonstrated that a partner's HPV-positive status increases the risk of HPV in women and men; similar observations have been reported elsewhere (Burchell et al., 2010) . HIV-negative couples were found to have a significantly lower prevalence of type-specific HPV concordance compared with couples in which both partners were HIV positive and HIV-discordant couples in which the female partner was HIV positive. HIV-positive and HIV-discordant couples where the female partner was HIV positive were more likely to share multiple HPV types, while HIV-negative couples were more likely to share single HPV types; this confirmed a previous report (Mbulawa et al., 2009) . The higher prevalence of type-specific HPV concordance in couples that were either HIV positive, or HIV discordant and where the female partner was HIV positive, HIV-positive women are reported to have a higher cervical HPV viral load compared with HIV-negative women. This has been associated with low CD4 count levels, suggesting that HIV co-infection may increase genital HPV viral load in women (Lefevre et al., 2004) . Bleeker et al. (2005) reported that female cervical-scrape specimens have a higher HPV viral load compared with male penile-scrape specimens. However, comparing HPV viral load between women and men may not be accurate because the number of cells obtained in female cervical samples is higher than that obtained in male penile samples (Bleeker et al., 2005; Flores et al., 2006) . Also, the different types of genital cell epithelium observed in women and men may provide different environments for HPV replication, the female environment being more favourable for producing high HPV viral loads (Flores et al., 2006) .
We and others have demonstrated that women and men with high HPV viral load more frequently share HPV compared with those with a lower HPV viral load (Bleeker et al., 2005; Mbulawa et al., 2009) . This supports the hypothesis that HPV transmission between sexually active couples could be enhanced by high HPV viral load. Female-to-male HPV transmission is reported to be more common compared with male-to-female HPV transmission, and the rate of HPV transmission from the cervix to the penis (17.4/100 personmonths of exposure) is higher than that from penis to cervix (4.9/100 person-months of exposure) (Hernandez et al., 2008) . The finding that a women's HPV risk was not influenced by her male partner's HIV status may be explained by the low rate of male-to-female HPV transmission, possibly due to less virus being available for transmission in men. Alternative reasons for the higher female-to-male HPV transmission rate need further investigation. The question of whether HIV infection leads to a significant increase in genital HPV viral load in men, as it does in women, also needs clarification.
In conclusion, results from this study demonstrated that male HIV status did not influence the prevalence of genital HPV (of any type), HR HPV or LR HPV in their female partner, whereas female HIV-positive status increased the risk of HPV infection of their male partner. We also demonstrated that, in men, type-specific HPV sharing with their female partner is influenced by their own HIV status and that of their female partner, while in women typespecific HPV sharing is influenced by their own HIV status and not that of their male partner. The data from this study substantially increase the very limited data reported on type-specific genital HPV sharing between sexually active couples, and especially for HIV-positive and HIV-discordant couples. A major strength of the present study was the large number of participating couples. The more data that are available on HPV transmission among sexually active couples, the more effective HPV-prevention strategies will be.
METHODS
Study population and specimen collection. A total of 486 heterosexually active couples were enrolled on this study. This report constitutes an expansion of a study reported previously (Mbulawa et al., 2009) in which 254 couples were enrolled. Among the 486 couples in the present study, 162 were couples in which both partners were HIV negative, 115 were couples in which both partners were HIV positive, 163 were HIV-discordant couples in which only the female partner was HIV positive and 46 were HIV-discordant couples in which only the male partner was HIV positive. The mean age of female and male participants was 35 years (range 18-66 years) and 38 years (range 19-67 years), respectively. Of the men in this study, 96.6 % (451/467) were circumcised and 11 declined to answer the question on circumcision. The study was approved by the Research Ethics Committee of the University of Cape Town. Cervical cells were collected using a Digene cervical sampler. Penile cells were collected with a dry Digene swab by thorough brushing of the penile shaft and glans as well as the foreskin in uncircumcised men. Both cervical and penile cells were stored in Digene transport medium at 280 uC until DNA was extracted.
HPV genotyping. DNA was extracted from both cervical and penile cells using a MagNA Pure Compact Nucleic Acid Isolation kit (Roche) and an automated MagNA Pure Compact machine (Roche). HPV typing was performed on DNA extracted from cervical and penile cells using a Roche Linear Array HPV Genotyping assay according to the manufacturer's instructions. The linear array has the capacity to detect 37 different HPV genotypes and the b-globin gene to evaluate sampling adequacy. HR HPV types included [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] 42, and IS39. The probable HR HPV types HPV-26, -53 and -66 were grouped with the HR HPV types. To ensure sample adequacy, the presence of the b-globin gene was evaluated and found to be negative in 0.4 % (2/ 486) of cervical samples and in 3.1 % (15/486) of penile samples. All b-globin-negative samples were excluded from the analysis.
Statistical analysis. All comparisons of HPV prevalence levels were conducted using x 2 tests. Factors affecting the risk of any HPV infection were assessed using multivariate logistic regression. Factors affecting the risk of sharing the same HPV type as one's partner were also assessed using multivariate logistic regression, but with the variance calculations adjusted to take into account clustering in the case of individuals whose partners had multiple HPV types (the denominator was the total number of HPV types detected in sexual partners, not the number of sexual partners). All analyses were conducted for HR HPV types and LR HPV types separately, as well as for HR HPV and LR HPV types combined. All statistical analyses were conducted using STATA 11.0 (StataCorp). In all analyses P values ¡0.05 were considered significant.
